Hubert C. Chen is the Chief Medical Officer of Pfenex Inc., a clinical-stage biotechnology company developing biosimilars, therapeutic equivalent peptides and novel vaccines. In his current role, Dr. Chen oversees clinical research, regulatory affairs, and product development. Previously, Dr. Chen served as vice president of clinical development at Aileron Therapeutics, vice president of translational medicine at Regulus Therapeutics, senior director of clinical research and corporate development at Amylin Pharmaceuticals, and associate director of medical sciences at Amgen. Dr. Chen was staff research investigator at the Gladstone Institutes and assistant clinical professor of medicine at UCSF. He received his residency training at Massachusetts General Hospital, MD from Columbia University, and BAS from Stanford University. Dr. Chen is board certified in Internal Medicine and Endocrinology.